Scholarlink

<p>Rapid hematopoietic regeneration post-hematopoietic stem cell transplantation (HSCT) is vital for prompt immune recovery, infection prevention, and averting complications such as anemia and thrombocytopenia. The hematopoietic stem cells (HSCs) produce mature blood cells through a process known as hematopoiesis that is tightly regulated by the hypoxic bone marrow microenvironment. However, the limited number of HSCs present in the bone marrow is one of the major challenges for successful HSCT. Hence, developing novel ex vivo expansion strategies that address the clinical limitations of the current HSCT becomes imperative. Our prior work demonstrated that priming of mesenchymal stromal cells (MSCs) with a hypoxia-mimetic compound, cobalt chloride (CoCl<sub>2;</sub> CoCl<sub>2</sub>-MSCs) promotes the expansion of functional HSCs co-cultured with them. In this study, we investigated the role of CoCl<sub>2</sub>-MSCs-derived microvesicles (Co-MVs) and exosomes (Co-Exo) in regulating hematopoietic stem and progenitor cells (HSPCs). MVs and exosomes from naïve and atmospheric hypoxia (1% O<sub>2</sub>)-primed MSCs were used as controls. We found that CoCl<sub>2</sub> induces the expression of Jagged-1-specific mRNA in the MSCs, which gets selectively partitioned into the Co-MVs. These Co-MVs, in turn, upregulate the expression of <i>Notch2</i> and <i>Hes1</i> in the HSPCs cultured with them. Furthermore, Co-MVs induce the expression of quiescence and self-renewal genes in the HSPCs and boost their long-term engraftment ability. These beneficial effects of Co-MVs on the functionality of HSPCs hold significant clinical implications as <i>cell-free</i> and <i>cost-effective</i> therapeutics in improving the success rate of HSCT.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Microvesicles secreted by CoCl2-primed mesenchymal stromal cells boost the functionality of hematopoietic stem cells cultured with them

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月7日

查看全文
  • Shalmali Pendse,
  • Vaijayanti Kale,
  • Anuradha Vaidya

摘要

Rapid hematopoietic regeneration post-hematopoietic stem cell transplantation (HSCT) is vital for prompt immune recovery, infection prevention, and averting complications such as anemia and thrombocytopenia. The hematopoietic stem cells (HSCs) produce mature blood cells through a process known as hematopoiesis that is tightly regulated by the hypoxic bone marrow microenvironment. However, the limited number of HSCs present in the bone marrow is one of the major challenges for successful HSCT. Hence, developing novel ex vivo expansion strategies that address the clinical limitations of the current HSCT becomes imperative. Our prior work demonstrated that priming of mesenchymal stromal cells (MSCs) with a hypoxia-mimetic compound, cobalt chloride (CoCl2; CoCl2-MSCs) promotes the expansion of functional HSCs co-cultured with them. In this study, we investigated the role of CoCl2-MSCs-derived microvesicles (Co-MVs) and exosomes (Co-Exo) in regulating hematopoietic stem and progenitor cells (HSPCs). MVs and exosomes from naïve and atmospheric hypoxia (1% O2)-primed MSCs were used as controls. We found that CoCl2 induces the expression of Jagged-1-specific mRNA in the MSCs, which gets selectively partitioned into the Co-MVs. These Co-MVs, in turn, upregulate the expression of Notch2 and Hes1 in the HSPCs cultured with them. Furthermore, Co-MVs induce the expression of quiescence and self-renewal genes in the HSPCs and boost their long-term engraftment ability. These beneficial effects of Co-MVs on the functionality of HSPCs hold significant clinical implications as cell-free and cost-effective therapeutics in improving the success rate of HSCT.